Genetic resistance to chemical hepatocarcinogenesis in the DRH rat strain

Comparative Medicine

Volumn 54, Issue 4, 2004, Pages 373-377

  Higashi, Ken ^a   Denda, Ayumi ^b   Higashi, Taneaki ^c   Hiai, Hiroshi ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c KOSHIEN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 DIMETHYLAMINO 3' METHYLAZOBENZENE; GLUTATHIONE S TRANSFERASE P; GLUTATHIONE TRANSFERASE; UNCLASSIFIED DRUG;

CANCER MODEL; CANCER RESISTANCE; CANCER SUSCEPTIBILITY; CELL DAMAGE; CHEMICAL CARCINOGENESIS; CHROMOSOME 1; CHROMOSOME 4; DNA ADDUCT; DRH1 GENE; DRH2 GENE; FEEDING; GENE; GENETIC ANALYSIS; GENETIC RESISTANCE; GENETIC SUSCEPTIBILITY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MATING SYSTEM; NONHUMAN; PHENOTYPE; QUANTITATIVE TRAIT LOCUS; RAT; RAT STRAIN; REVIEW;

ANIMALS; CARCINOMA, HEPATOCELLULAR; DNA ADDUCTS; HEPATECTOMY; HEPATOCYTES; IMMUNITY, NATURAL; LIVER NEOPLASMS, EXPERIMENTAL; METHYLDIMETHYLAMINOAZOBENZENE; RATS; RATS, INBRED STRAINS;

EID: 4143062921     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Balmain, A. 2000. Cancer as a complex genetic trait: tumor susceptibility in humans and mouse models. Cell 108:145-152.
2. Clemens, M. P. 1991. Free radicals in chemical carcinogenesis. Klin. Wochenschr. 69:1123-1134.
3. Columbano, A., G. M. Ledda, P. Sirigu, T. Perra, and P. Pani. 1983. Liver cell proliferation induced by a single dose of lead nitrate. Am. J. Pathol. 110:83-88.
4. Columbano, A., G. M. Ledda-Columbano, M. G. Ennas, M. Curto, A. Chelo, and P. Pani. 1990. Cell proliferation and promotion of rat liver carcinogenesis: different effect of hepatic regeneration and mitogen induced hyperplasia on the development of enzyme-altered foci. Carcinogenesis 11:771-776.
5. DeMiglio, M. R., F. Canzian, R. M. Pascale, M. M. Simile, M. R. Muroni, D. F. Calvisi, G. Romeo, and F. Fee. 1999. Identification of genetic loci controlling hepatocarcinogenesis on rat chromosome 7 and 10. Cancer Res. 59:4651-4657.
6. DeMiglio, M. R, R. M. Pascale, M. M. Simile, M. R. Muroni, D. F. Calvisi, P. Virdis, G. M. Bosinco, M. Frau, M. A. Seddaiu, S. Ladu, and F. Feo. 2002. Chromosome mapping of multiple loci affecting the predisposition to rat liver carcinogenesis. Cancer Res. 62:4459-4463.
7. Denda, A., W. Kitayama, Y. Konishi, Y. Yan, Y. Fukamachi, M. Miura, S. Gotoh, K. Ikemura, T. Higashi, and K. Higashi. 1999. Genetic properties for the suppression of development of putative preneoplastic glutathione S-transferase placental form-positive foci in the liver of carcinogen-resistant DRH strain rats. Cancer Lett. 140:59-67.
8. Di Ilio, C., A. Aceto, A. Columbano, G. M. Ledda-Columbano, and G. Federici. 1989. Induction of rat liver glutathione transferase subunit 7 by lead nitrate. Cancer Lett. 46:167-171.
9. Farber, E. 1984. The biochemistry of preneoplastic liver: a common metabolic pattern in hepatocyte nodules. Can. J. Biochem. Cell Biol. 62:743-764.
10. Fiala, S, A. Mohindru, W. G. Kettering, A. E. Fiala, and H. P. Morris. 1976. Glutathione and gamma glutamyl transpeptidase in rat liver during chemical carcinogenesis. J. Natl. Cancer Inst. 57:591-598.
11. Fornace, A. J., Jr., D. W. Nebert, M. C. Hollander, J. D. Luethy, M. Papathanasiou, J. Fargnoli, and N. J. Holbrook. 1989. Mammalian genes, coordinately regulated by growth arrest signals and DNA-damaging agents. Mol. Cell. Biol. 9:4196-4203.
12. 6-methylguanine-DNA methyltransferase in rat hepatoma cells exposed to DNA-damaging agents. Jpn. J. Cancer Res. 89:72-77.
13. Gerlyng, P., A. Abyholm, T. Gromoto, B. Erikstein, H. S. Huitfeldt, T. Stokke, and P. O. Seglen. 1993. Binucleation and polyploidization patterns in developmental and regenerative rat liver growth. Cell Prolif. 26:557-565.
14. Gotoh, S., N. Todaka, Y. Yan, Y. Fukamachi, T. Abe, and K. Higashi. 1999. Studies on the multidrug resistance gene expression in the livers of rats associated with different susceptibility of hepatocarcinogenesis. J. Univ. Occup. Environ. Health 21:267-276.
15. Hammad, H., T. Higashi, N. Tateishi, M. Hanatani, and Y. Sakamoto. 1990. Lipid peroxidation in the liver of carcinogen-resistant rats. Biochim. Biophys. Acta 1045:99-106.
16. Haupt, Y., R. Maya, A. Kazaz, and M. Oren. 1997. Mdm2 promotes the rapid degradation of p53. Nature 387:296-299.
17. Higashi, T., R. Fukui, R. M. Sekiya, F. Yoshimoto, N. Tateishi, and Y. Sakamoto. 1986. Decrease induction of gamma-glutamyltranspeptidase activity by 3′-methyl-4-dimethylaminoazobenzene in the rats given carcinogen- containing diet for several generations. Jpn. J. Cancer Res. 77:139-144.
18. Hirano, T., K. Higashi, A. Sakai, Y. Tsurudome, Y. Ootsuyama, R. Kido, and H. Kasai. 2000. Analysis of oxidative DNA damage and its repair activity in the livers of 3′-methyl·4-dimethylaminoazobenzene-treated rodents. Jpn. J. Cancer Res. 91:681-685.
19. Kageyama, H., T. Hiwasa, K. Tokunaga, and S. Sakiyama. 1988. Isolation and characterization of a complementary DNA clone for a Mr 32,000 protein which is induced with tumor promoters in BALB/C 3T3 cells. Cancer Res. 48:4795-4798.
20. Kato, T., K. Imaida, K. Ogawa, R. Hasegawa, T. Shirai, and M. Tatematsu. 1993. Three dimensional analysis of glutathione S-transferase placental form-positive lesion development in early stages of rat hepatocarcinogenesis. Jpn. J. Cancer Res. 84:1252-1257.
21. Koop, D. R. 1992. Oxidative and reductive metabolism by cytochrome p-450 2E1. FASEB J. 6:724-730.
22. Kubbutat, M. H. G., S. N. Jones, and K. H. Vousden. 1997. Regulation of p53 stability by mdm2. Nature 387:299-303.
23. Ledda-Columbano, G. M., A. Columbano, M. Curto, M. G. Ennas, P. Coni, D. S. Sar, and P. Pani. 1989. Further evidence that mitogen-induced cell proliferation does not support the formation of enzyme-altered islands in rat liver by carcinogens. Carcinogenesis 10:847-850.
24. Lee, G. H., G. Merlino, and N. Fausto. 1992. Development of liver tumors in transforming growth factor alpha transgenic mice. Cancer Res. 52:5162-5170.
25. Li, Z. G., Y. Shimada, F. Sato, M. Maeda, A. Itami, J. Kaganoi, I. Komoto, A. Kawabe, and M. Imamura. 2002. Inhibitory effects of epigallocatechin-3-gallate on N-nitrosomethyl-benzylamine-induced esophageal tumorigenesis in F344 rats. Int. J. Oncol. 21:275-1283.
26. Liu, H., K. Nobumoto, Y. Yamada, K. Higashi, and H. Hiai. 2003. Modulation of genetic resistance to hepatocarcinogenesis in DRH rats by partial hepatectomy. Cancer Lett. 196:13-16.
27. Loft, S., X. S. Deng, J. Tuo, A. Wellejus, M. Sorensen, and H. E. Poulsen. 1998. Experimental study of oxidative DNA damage. Free Radic. Res. 29:525-539.
28. Masuda, S. 1990. Mechanism of resistance to hepatocarcinogenic action of 3′-methyl-4-dimethyl-aminoazobenzene in genetically carcinogen-resistant rats. Med. J. Osaka Univ. 42:103-117. (in Japanese, abstract in English)
29. Mise-Omata, S., T. Sugiura, K. Higashi, and U. Yamashita. 1999. Reduced T cell response in carcinogen-sensitive Donryu rats compared with carcinogen-resistant DRH rats. Jpn. J. Cancer Res. 90:1277-1284.
30. Ogiso, T., M. Tatematsu, S. Tamano, H. Tsuda, and N. Ito. 1985. Comparative effects of carcinogens on the induction of placental glutathione S-transferase-positive liver nodules in a short-term assay and hepatocellular carcinomas in a long-term assay. Toxicol. Pathol. 13:257-265.
31. Parke, D.V. 1994. The cytochrome P450 and mechanisms of chemical carcirogenesis. Environ. Health Perspect. 102:852-853.
32. Pascale, R. M., M. M. Simile, M. R. DeMiglio, M. R. Muroni, D. F. Calvisi, G. Asara, D. Casabona, M. Frau, M. A. Seddaiu, and F. Feo. 2002. Cell cycle deregulation in liver lesions of ràts rats with and without genetic predisposition to hepatocarcinogenesis. Hepatology 35:1341-1350.
33. Pitot, H. C. and A. E. Sirica. 1980. The stages of initiation and promotion in hepatocarcinogenesis. Biochim. Biophys. Acta 605:191-215.
34. Saeter, G., P. E. Schwarze, J. M. Nesland, N. Juul, E. O. Pettersen, and P. O. Seglen. 1988. The polyploidizing growth pattern of normal rat liver is replaced by divisional, diploid growth in hepatocellular nodules and carcinomas. Carcinogenesis 9:939-945.
35. Sakamoto, Y., T. Higashi, and N. Tateishi. 1983. Factors involved in the appearance and switch-off of hepatic gamma-glutamyl transpeptidase. Gann Monogr. Cancer Res. 29:281-289.
36. Schally, A. V. and J. L. Varga. 1999. Antagonistic analogs of growth hormone-releasing hormone: new potential anti-tumor agents. Trends Endcr. Metab. 10:383-391.
37. Styles, J., B. M. Elliot, P. A. Lefevre, M. Robinson, N. Prichard, D. Hart, and J. Ashby. 1985. Irreversible depression in the ratio of tetraptoid:diploid liver nuclei in rats treated with 3′-methyl-4- dimethylaminoazobenzene (3′-M). Carcinogenesis. 6:.21-28.
38. Tashiro, K., M. Hagiya, T. Nishizawa, T. Seki, M. Shimonishi, S. Shimizu, and T. Nakamura. 1990. Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues. Proc. Natl. Acad. Sci. USA 87:3200-3204.
39. Wood, G. A., D. S. Sarma, and M. C. Archer. 2002. Tissue-specific resistance to cancer development in the rat: phenotypes of tumor-modifier genes. Carcinogenesis 23:1-9.
40. Yamashiro, K., Y. Yan, Y. Fukamachi, S. Gotoh, K. Higashi, M. Otsuki, Y. Hamada, and T. Higashi. 2000. Blunt cell growth potential in carcinogen resistant inbred rats. Exp. Anim. 49:47-50.
41. Yan, Y., K. Higashi, A. Tanimoto, Y. Fukamachi, H. Itoh, T. Abe, and T. Higashi. 1998. Remarkable difference in the incidence of liver tumors by N-nitrosodimethylamine in carcinogen-resistant DRH rat and its parental strain Donryu rat. J. Univ. Occup. Environ. Health 20:307-314.
42. Yan, Y., K. Higashi, K. Yamamura, Y. Fukamachi, T. Abe, S. Gotoh, T. Sugiura, T. Hirano, T. Higashi, and M. Ichiba. 1998. Different responses other than the formation of DNA-adducts between the livers of carcinogen-resistant (DRH) rats and carcinogen-sensitive (Donryu) rats to 3′-methyl-4- dimethylaminoazobenzene administration. Jpn. J. Cancer Res. 89:806-813.
43. Yan, Y., Z-Z. Zeng, S. Higashi, A. Denda, Y. Konishi, S. Onishi, H. Ueno, K. Higashi, and H. Hiai. 2002. Resistance of DRH strain rats to chemical carcinogenesis of liver: genetic analysis of later progression stage. Carcinogenesis 23:189-196.
44. Yano, M., T. Higashi, S. Kano, N. Tateishi, Y. Kido, T. Mori, K. Higashi, and Y. Sakamoto. 1989. Decreased activation of carcinogens in the liver of carcinogen-resistant rats. Cancer Res. 49:5352-5357.
45. Yoshimoto, F., S. Masuda, T. Higashi, T. Nishii, I. Takamisawa, N. Tateishi, and Y. Sakamoto. 1985. Comparison of drug-metabolizing activities in the livers of carcinogen-sensitive parent rats and carcinogen-resistant descendants. Cancer Res. 45:6155-6159.
46. Zeng, Z-Z., S. Higashi, W. Kitayama, A. Denda, Y. Yan, K. Matsuo, Y. Konishi, H. Hiai, and K. Higashi. 2000. Genetic resistance to chemical carcinogen-induced preneoplastic hepatic lesions in DRH strain rats. Cancer Res. 60:2876-2881.